Cargando…
Impact of disease-modifying therapy on dendritic cells and exploring their immunotherapeutic potential in multiple sclerosis
Dendritic cells (DCs) are the most potent professional antigen-presenting cells (APCs), which play a pivotal role in inducing either inflammatory or tolerogenic response based on their subtypes and environmental signals. Emerging evidence indicates that DCs are critical for initiation and progressio...
Autores principales: | Liu, Caiyun, Zhu, Jie, Mi, Yan, Jin, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743681/ https://www.ncbi.nlm.nih.gov/pubmed/36510261 http://dx.doi.org/10.1186/s12974-022-02663-z |
Ejemplares similares
-
The Long Road of Immunotherapeutics against Multiple Sclerosis †
por: Apostolopoulos, Vasso, et al.
Publicado: (2020) -
Recent progress in epidemiology, clinical features, and therapy of multiple sclerosis in China
por: Wang, Meng, et al.
Publicado: (2023) -
Dendritic Cells and Their Immunotherapeutic Potential for Treating Type 1 Diabetes
por: Khan, Farhan Ullah, et al.
Publicado: (2022) -
Risks and risk management in modern multiple sclerosis
immunotherapeutic treatment
por: Klotz, Luisa, et al.
Publicado: (2019) -
Role of the Immunogenic and Tolerogenic Subsets of Dendritic Cells in Multiple Sclerosis
por: Xie, Zhong-Xiang, et al.
Publicado: (2015)